Wu J, Kung J, Dong J, Chang L, Xie C, Habib A, et al. Distinct Connectivity and Functionality of Aldehyde Dehydrogenase 1a1-Positive Nigrostriatal Dopaminergic Neurons in Motor Learning. Cell Rep. 2019;28:1167-1181.e7 pubmed publisher

Matheoud D, Cannon T, Voisin A, Penttinen A, Ramet L, Fahmy A, et al. Intestinal infection triggers Parkinson's disease-like symptoms in Pink1-/- mice. Nature. 2019;571:565-569 pubmed publisher

van Kessel S, Frye A, El Gendy A, Castejon M, Keshavarzian A, van Dijk G, et al. Gut bacterial tyrosine decarboxylases restrict levels of levodopa in the treatment of Parkinson's disease. Nat Commun. 2019;10:310 pubmed publisher

Tomas D, Stanic D, Chua H, White K, Boon W, Horne M. Restoration of the Dopamine Transporter through Cell Therapy Improves Dyskinesia in a Rat Model of Parkinson's Disease. PLoS ONE. 2016;11:e0153424 pubmed publisher

Ren Z, Yang N, Ji C, Zheng J, Wang T, Liu Y, et al. Neuroprotective effects of 5-(4-hydroxy-3-dimethoxybenzylidene)-thiazolidinone in MPTP induced Parkinsonism model in mice. Neuropharmacology. 2015;93:209-18 pubmed publisher

Wienecke J, Ren L, Hultborn H, Chen M, Møller M, Zhang Y, et al. Spinal cord injury enables aromatic L-amino acid decarboxylase cells to synthesize monoamines. J Neurosci. 2014;34:11984-2000 pubmed publisher

Lindenbach D, Palumbo N, Ostock C, Vilceus N, Conti M, Bishop C. Side effect profile of 5-HT treatments for Parkinson's disease and L-DOPA-induced dyskinesia in rats. Br J Pharmacol. 2015;172:119-30 pubmed publisher

Mango D, Bonito Oliva A, Ledonne A, Cappellacci L, Petrelli R, Nisticò R, et al. Adenosine A1 receptor stimulation reduces D1 receptor-mediated GABAergic transmission from striato-nigral terminals and attenuates l-DOPA-induced dyskinesia in dopamine-denervated mice. Exp Neurol. 2014;261:733-43 pubmed publisher

Wang Y, Wang H, Wang T, Huang C, Liu J. L-DOPA-induced dyskinesia in a rat model of Parkinson's disease is associated with the fluctuational release of norepinephrine in the sensorimotor striatum. J Neurosci Res. 2014;92:1733-45 pubmed publisher

Ko W, Martin Negrier M, Bezard E, Crossman A, Ravenscroft P. RGS4 is involved in the generation of abnormal involuntary movements in the unilateral 6-OHDA-lesioned rat model of Parkinson's disease. Neurobiol Dis. 2014;70:138-48 pubmed publisher

Dragicevic E, Poetschke C, Duda J, Schlaudraff F, Lammel S, Schiemann J, et al. Cav1.3 channels control D2-autoreceptor responses via NCS-1 in substantia nigra dopamine neurons. Brain. 2014;137:2287-302 pubmed publisher

Szczesna K, de la Caridad O, Petazzi P, Soler M, Roa L, Sáez M, et al. Improvement of the Rett syndrome phenotype in a MeCP2 mouse model upon treatment with levodopa and a dopa-decarboxylase inhibitor. Neuropsychopharmacology. 2014;39:2846-56 pubmed publisher

Navailles S, Milan L, Khalki H, Di Giovanni G, Lagière M, De Deurwaerdère P. Noradrenergic terminals regulate L-DOPA-derived dopamine extracellular levels in a region-dependent manner in Parkinsonian rats. CNS Neurosci Ther. 2014;20:671-8 pubmed publisher

Wang Y, Zhang Q, Wang H, Wang T, Liu J. Genome-wide microarray analysis identifies a potential role for striatal retrograde endocannabinoid signaling in the pathogenesis of experimental L-DOPA-induced dyskinesia. Synapse. 2014;68:332-43 pubmed publisher